Ovarian Cancer and Us - best viewed in FIREFOX

Google Search: this blog, links from posts and the web.....

Loading...

Friday, June 11, 2010

ASCO Annual Meeting: Ovarian Cancer: Some Hope in the Quest for an Effective Screening Method



Note: "The prospective study of 3,238 postmenopausal women aged 50 to 74 with no significant family history of breast or ovarian cancer, enrolled over a course of nine years."
CHICAGO—In the continuing quest for an effective screening method to detect ovarian cancer at an early stage, a new approach using an algorithm has shown promise in early testing as reported here at the ASCO Annual Meeting and featured beforehand in a teleconference by the society.

online: NCCS What Do You Wish You Had Known? (U.S.)



What Do You Wish You Had Known?

Most cancer survivors in the U.S. don’t have a cancer treatment plan, treatment summary, or follow-up survivorship care plan. So it’s no surprise, they and their doctors don’t always know what signs and symptoms of long-term and late-term effects to look for or how choices they made at the beginning of treatment might affect their well-being down the road.

What was your experience? Did you have to go back to your doctor again and again to demand a chest x-ray for a cough that was dismissed as allergies? Did your doctor tell you that you’d need bone density scans ahead of time to ward off chemo-related bone loss? Did you sail through treatment only to be hit by a wave of depression after the fact?

Please help us to collect stories from everyone – survivors, caregivers, and providers – across all 50 states, to illustrate what surviving cancer looks like today. Please share a short note about how knowing what to expect ahead of time – or not knowing at all – has affected your health and well-being.
http://www.canceradvocacy.org/take-action/share-your-story.html

Exploring the Interface Between Cancer and Psychiatry - Cancer Network



"As a psychiatrist who has cancer, I have developed a deep understanding of the ways in which our training can help us help patients who find themselves forced to deal with the complicated emotional aspects that accompany this disease. My hope is that my insights will help psychiatrists as they wrestle with the problems that plague their patients who are coping with this difficult disease....."

The drug, Patupilone, failed to show improvements over existing drugs in 829 patients with advanced ovarian cancer.




An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis



Conclusions
Current evidence suggests many health benefits from physical activity during and post cancer treatments. Additional studies are needed in cancer diagnoses other than breast and with a focus on survivors in greatest need of improvements for the health outcomes of interest.

A Mechanism Behind Negative Tumor Suppressor Gene Function Identified - p53



Note: the p53 gene has been studied extensively for decades including p53 vaccines, hopefully new research will move research on p53 quickly as its implications in cancer will have a great impact

2010 Institute for Continuing Healthcare Education - Ovarian Cancer Screening and Management to Improve Patient Survival



OVERVIEW

Ovarian cancer is the leading cause of death from gynecologic malignancy and the fifth leading cause of cancer‐related death among women in the United States. The high mortality rate associated with ovarian cancer is due in part to the lack of effective screening strategies to detect the disease in early stages (I or II) when the cancer is confined to the ovary. Since symptoms associated with ovarian cancer are typically nonspecific, a clinical diagnosis is difficult to make until the disease has advanced. The Institute for Continuing Healthcare Education has identified a number of areas related to the screening, diagnosis, and treatment of ovarian cancer where education is vital in order to address the need for improvement in professional care.

PROGRAM DESCRIPTION

In this Webcast, the faculty members will present up-to-date, relevant information on screening guidelines, referral procedures, and therapies for ovarian cancer. As a learning reinforcement, individuals who complete this activity will be able to request a certified monograph with two case studies pertaining to the treatment strategies discussed within the Webcast.

INSTRUCTIONS FOR OBTAINING CME/CE CREDIT

There are no fees or prerequisites for participating in and receiving CME/CE credit for this online educational activity.

Peripheral neuropathy — Managing the side effects of chemotherapy - MayoClinic.com



Ovarian cancer: the duplicity of CA125 measurement : Nature Reviews Clinical Oncology



Avastin/Dr Burger video and text ASCO 2010